Genus Healthcare Solution And It Consulting Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 10 Year, 12 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 M
as on 24-10-2024
- Revenue -79.98%
(FY 2023)
- Profit -277.70%
(FY 2023)
- Ebitda -164.15%
(FY 2023)
- Net Worth -116.90%
(FY 2023)
- Total Assets -11.76%
(FY 2023)
About Genus Healthcare Solution And It Consulting
The Company is engaged in the Education Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.00 M.
Hans Raj, Monika Verma, Vikas Maheshwari, and Seven other members serve as directors at the Company.
- CIN/LLPIN
U74120UP2014PTC067581
- Company No.
067581
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Dec 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Genus Healthcare Solution And It Consulting?
Board Members(10)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Somesh Bhatt  | Additional Director | 12-Jan-2018 | Current |
| Satya Rai | Additional Director | 15-Feb-2018 | Current |
| Hans Raj | Director | 15-Feb-2018 | Current |
| Monika Verma | Director | 12-Dec-2014 | Current |
| Vikas Maheshwari | Director | 12-Dec-2014 | Current |
| Rajendra Singh | Additional Director | 12-Jan-2018 | Current |
Financial Performance of Genus Healthcare Solution And It Consulting.
Genus Healthcare Solution And It Consulting Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 79.98% decrease. The company also saw a substantial fall in profitability, with a 277.7% decrease in profit. The company's net worth observed a substantial decline by a decrease of 116.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genus Healthcare Solution And It Consulting?
In 2023, Genus Healthcare Solution And It Consulting had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Biogen Labs And Diagnostic Private LimitedActive 6 years 8 months
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Mar 2018 | ₹4.00 M | Open |
How Many Employees Work at Genus Healthcare Solution And It Consulting?
Unlock and access historical data on people associated with Genus Healthcare Solution And It Consulting, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genus Healthcare Solution And It Consulting, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genus Healthcare Solution And It Consulting's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
